Position in ALKS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$36,713,902
+$11,939,025 QoQ
Shares Held
700,647
0.0% QoQ
Ownership
0.418%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
#48
of 421 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Frazier Life Sciences Management, L.P. holds $95,063,117 across 3 Drug Manufacturers - Specialty & Generic names. ALKS ranks #2 (38.6% of the industry book) .
All Filings in ALKS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,713,902 | 700,647 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $24,774,877 | 700,647 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $19,604,103 | 700,647 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $21,019,410 | 700,647 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $28,628,510 | 1,000,647 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $19,849,279 | 601,129 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $17,288,470 | 601,129 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $16,125,850 | 576,129 | Shares | Sole | 2024-11-15 | |
| No filing history on record for this holder in this stock. | ||||||